COMBINED USE OF AN ALPHA-ADRENOCEPTOR ANTAGONIST AND A MUSCARINIC ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
This invention relates to pharmaceutical combinations suitable for treating the lower urinary tract symptoms associated with benign prostatic hyperplasia in men, which combinations contain- an alpha-adrenoceptor antagonist and a muscarinic antagonist. The combinations of the invention are particularly suitable for treating moderate or severe lower urinary tract symptoms.